Talis Biomedical (TLIS) Institutional Ownership → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free TLIS Stock Alerts $8.80 -0.18 (-2.00%) (As of 09:30 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Talis Biomedical (NASDAQ:TLIS)CurrentInstitutional OwnershipPercentage43.77%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$348.83KNumber ofInstitutional Sellers(last 12 months)0 Get TLIS Insider Trade Alerts Want to know when executives and insiders are buying or selling Talis Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TLIS Institutional Buying and Selling by Quarter Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some Talis Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/30/2024 BML Capital Management LLC42,743$318K0.2%N/A2.349% 12/6/2023 Citigroup Inc.5,267$30K0.0%N/A0.289% 5/17/2022Greenlight Capital Inc.2,235,783$3.15M0.2%+42.5%8.399% 5/9/2022 Qube Research & Technologies Ltd47,467$67K0.0%-19.8%0.178% 2/14/2022Greenlight Capital Inc.1,569,300$6.29M0.4%N/A5.969% 2/10/2022 Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225% Get the Latest News and Ratings for TLIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter. 2/4/2022 Mercer Global Advisors Inc. ADV11,035$44K0.0%-44.9%0.042% 2/1/2022 Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225% 11/18/2021 Personal CFO Solutions LLC17,000$106K0.0%N/A0.065% 11/17/2021 ArrowMark Colorado Holdings LLC5,893,876$36.84M0.3%+0.4%22.420% 11/12/2021 Geode Capital Management LLC302,968$1.89M0.0%+17.4%1.179% 11/9/2021 BlackRock Inc.813,137$5.08M0.0%+0.7%3.165% 11/4/2021 Deutsche Bank AG15,007$94K0.0%+85.9%0.058% 9/3/2021Parametric Portfolio Associates LLC50,496$557K0.0%+21.3%0.197% 8/25/2021 Marshall Wace LLP11,326$125K0.0%-80.2%0.044% 8/17/2021 ArrowMark Colorado Holdings LLC5,871,925$32.69M0.2%-2.2%22.856% 8/16/2021 Cubist Systematic Strategies LLC22,920$253K0.0%N/A0.089% 8/16/2021 Redmile Group LLC363,849$4.01M0.1%-9.0%1.416% 8/16/2021 Alyeska Investment Group L.P.100,000$1.10M0.0%+100.0%0.389% 8/16/2021 Morgan Stanley442,250$4.88M0.0%+2,458.6%1.721% 8/16/2021 Charles Schwab Investment Management Inc.95,996$1.06M0.0%+2.5%0.374% 8/16/2021 State Street Corp205,925$2.27M0.0%+40.0%0.802% 8/16/2021 Nuveen Asset Management LLC40,060$442K0.0%+87.1%0.156% 8/16/2021 Federated Hermes Inc.15,000$165K0.0%-98.5%0.058% 8/16/2021 Marshall Wace LLP11,326$125K0.0%-80.2%0.044% 8/13/2021 Geode Capital Management LLC258,043$2.85M0.0%+11.2%1.006% 8/13/2021 Vanguard Group Inc.544,906$6.01M0.0%+39.7%2.125% 8/12/2021 JPMorgan Chase & Co.42,230$466K0.0%-73.4%0.165% 8/11/2021 Bank of New York Mellon Corp84,983$938K0.0%+6.3%0.331% 8/11/2021 BlackRock Inc.807,299$8.90M0.0%+11.8%3.149% 8/10/2021 Nicholas Investment Partners LP1,071,315$11.82M0.7%-2.7%4.179% 8/5/2021 Legato Capital Management LLC18,585$205K0.0%N/A0.072% 8/5/2021 Capital Analysts LLC3,600$40K0.0%N/A0.014% 8/5/2021 Rhumbline Advisers12,976$143K0.0%N/A0.051% 8/2/2021 New York State Common Retirement Fund38,414$424K0.0%-2.9%0.150% 6/10/2021 Perceptive Advisors LLC250,000$3.21M0.0%N/A0.975% 5/18/2021 Baker BROS. Advisors LP7,574,835$97.34M0.4%N/A29.545% 5/18/2021 Tudor Investment Corp Et Al10,000$129K0.0%N/A0.039% 5/18/2021 Redmile Group LLC400,000$5.14M0.1%N/A1.560% 5/18/2021 Alyeska Investment Group L.P.50,000$643K0.0%N/A0.195% Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 20245/18/2021 Boxer Capital LLC1,550,998$19.93M0.7%N/A6.050% 5/18/2021 California State Teachers Retirement System19,965$257K0.0%N/A0.078% 5/17/2021 Perceptive Advisors LLC250,000$3.21M0.0%N/A0.975% 5/17/2021 Caas Capital Management LP40,000$514K0.0%N/A0.156% 5/17/2021 Nuveen Asset Management LLC21,415$275K0.0%N/A0.084% 5/14/2021 Laurion Capital Management LP10,000$129K0.0%N/A0.039% 5/14/2021 Nicholas Investment Partners LP1,101,401$14.15M1.0%N/A4.296% 5/14/2021 Sectoral Asset Management Inc405,094$5.21M0.4%N/A1.580% 5/13/2021 Bank of New York Mellon Corp79,941$1.03M0.0%N/A0.312% 5/13/2021 Federated Hermes Inc.1,030,000$13.24M0.0%N/A4.017% 5/12/2021 Northern Trust Corp138,481$1.78M0.0%N/A0.540% 5/12/2021 Geode Capital Management LLC232,026$2.98M0.0%N/A0.905% 5/12/2021 JPMorgan Chase & Co.158,683$2.04M0.0%N/A0.619% 5/12/2021 UBS Group AG3,211$41K0.0%N/A0.013% 5/11/2021 Mercer Global Advisors Inc. ADV20,035$257K0.0%N/A0.078% 5/11/2021 New York State Common Retirement Fund39,553$508K0.0%N/A0.154% 5/7/2021 BlackRock Inc.722,407$9.28M0.0%N/A2.818% 5/7/2021 American International Group Inc.7,715$99K0.0%N/A0.030% 5/6/2021 M&T Bank Corp15,202$195K0.0%N/A0.059% 4/27/2021 Janney Montgomery Scott LLC10,000$128K0.0%N/A0.039% (Data available from 1/1/2016 forward) TLIS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLIS shares? During the previous two years, the following institutional investors and hedge funds held shares of Talis Biomedical shares: BML Capital Management LLC ($318K), Citigroup Inc. ($30K).Learn more on TLIS's institutional investors. What percentage of Talis Biomedical stock is owned by institutional investors? 43.77% of Talis Biomedical stock is owned by institutional investors. Learn more on TLIS's institutional investor holdings. Which institutional investors have been buying Talis Biomedical stock? The following institutional investors have purchased Talis Biomedical stock in the last 24 months: BML Capital Management LLC ($42.74K), and Citigroup Inc. ($5.27K). How much institutional buying is happening at Talis Biomedical? Institutional investors have bought a total of 48,010 shares in the last 24 months. This purchase volume represents approximately $348.83K in transactions. Related Companies: AXDX Major Shareholders HLTH Major Shareholders OMIC Major Shareholders LUCD Major Shareholders BNGO Major Shareholders CCLD Major Shareholders QTI Major Shareholders AYTU Major Shareholders VAXX Major Shareholders VBIV Major Shareholders This page (NASDAQ:TLIS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
